Last checked
RefreshEstimated news impact scores by coin. Scores are not price-change percentages.
Check failed. Showing saved news from .
Fund managers choosing where to launch face two different requirements: open, composable markets, or confidential, multi-party institutional workflows. Onyx, Enzyme's fund infrastructure, runs on EVM today. It's coming to Canton next. @Enzymefinance on what that choice adds.
AN UPDATE ON MLN Earlier last week, Binance announced the upcoming delisting of MLN. Enzyme was neither informed ahead of the announcement nor provided with a precise reason for the decision, similarly to when MLN was added to the monitoring list, preventing us from sharing further details with the community. As delisting decisions can involve many factors and in the absence of further explanations, we want to clarify that this decision is not related to operational concerns regarding Enzyme. While we are naturally disappointed by the outcome, MLN remains listed on several major centralized exchanges. Most importantly, Enzyme is stronger today than at any point in its 9-year history. Since the launch of Onyx in Q4 2025, more than 10 asset managers have adopted our tokenized fund infrastructure, powering products ranging from tokenized hedge funds and gold trackers to private credit and money market funds. Onyx AUT continues to grow and now exceeds the historical protocol, with revenues tracking at ATH. Our pipeline also keeps expanding despite difficult market conditions, marking a clear contrast with previous bear markets that pushed much of the industry into standby mode. April marked the strongest month in Enzyme’s history, and momentum continues to build. Cross-chain deposits, synchronous subscriptions, NAV automation, integrations with Octav and 1Token, as well as upcoming extensions to Canton and Rayls are only a few examples of what we have achieved recently. We remain deeply committed to pushing this industry forward and helping establish decentralized infrastructure as the backbone of next-generation financial markets.
Enzyme is joining @RaylsLabs as a launch partner 💪 Onyx & Myso will be live on Rayls from day one. Institutional-grade tokenized fund infrastructure, ready from the start. Read more: https://enzyme.finance/blog-posts/enzyme-arrives-on-rayls
Private credit is moving on-chain. Loan mechanics, collateral management, settlement flows... all enforced on-chain with full compliance controls. @credilabs and @turtledotxyz launched exactly that, built on Enzyme. 👇
Great to see @credilabs just launched a private credit vault built on Enzyme, brought to market by @turtledotxyz. More real-world yield strategies finding their home on-chain. 🤝
MiCA has been on everyone's radar for a while but actual approvals have been slow. Seeing a bank of ClearBank's size get through it signals that the regulatory path in Europe is becoming more concrete for the whole industry. For anyone building tokenized fund infrastructure in Europe, Enzyme is already MiCA-ready. Happy to walk through what that looks like in practice.
Just In: Binance announced that it has added seven tokens—FARM, HIGH, MLN, RESOLV, SYS, TRU, and VELODROME—to its “Monitoring” list. This means they might be delisted. Tether Gold (XAUT) will have its seed tag removed.
The market might be down, but you know what’s up? Our KPIs. • Enzyme Myso passed $100M notional • Enzyme Onyx reached $50M AUT since its launch in November Even the bear can’t short momentum. 🐻
Product issuers, in case you missed this one 👀 Together with @particula_io, we are empowering asset managers and product issuers to streamline the launch of risk-rated tokenized investment products and facilitate institutional distribution across the onchain economy. Worth a revisit if you’re building tokenized products 👉 https://enzyme.finance/blog-posts/enzyme-and-particula-announce-strategic-partnership-to-enhance-the-industry-standard-for-risk-rated-onchain-rwas?utm_source=x&utm_medium=organic&utm_content=post
How useful is a tokenized product if issuers can’t clearly see the risks behind it? Enzyme x @particula_io solves this. Particula's risk framework integrates with Enzyme Onyx, so tokenized funds come with independent risk ratings from day one. Learn more: https://t.co/fSSTDtZqz9
“Onyx lets us structure and run our entire fund stack without ever touching custom infrastructure” - Eriz Zarate (@its_eriz), Founder of https://t.co/XidTt6mu0w This is exactly what Enzyme Onyx was built for: a core stack that lets managers issue and operate tokenized hedge funds. Curious? Let’s talk: https://t.co/2KeMkkLUIq
If you can build the strategy, you shouldn’t have to build the infrastructure. Enzyme Onyx gives asset managers what they need to run tokenized fund strategies without custom systems or backend engineering. With built-in accounting, fee frameworks, and controlled deposit/redemption flows, Onyx lets managers structure and operate their day-to-day strategies fully on-chain while staying in control of every administrative decision. Explore Enzyme Onyx: https://t.co/khpikdKbHe
Fund platforms can leverage Enzyme Onyx as their core stack to enable their clients to deploy tokenized funds seamlessly. @cv5capital is already doing it. Here’s how: https://www.enzyme.finance/blog-posts/enzyme-partners-with-cv5-capital-to-power-a-new-generation-of-regulated-funds https://t.co/btoxwrk2ug
Did you know you can now use @Ledger to run a hedge fund? Passif runs its delta-neutral hedge fund fully on-chain through Enzyme Onyx, executing its decentralized strategy using Ledger Wallet. Read the full story: https://www.enzyme.finance/blog-posts/deploying-a-fully-decentralized-hedge-fund-with-enzyme-onyx?utm_source=x&utm_medium=organic&utm_content=post https://t.co/fYOzDFs72y
OKX announced the delisting of several spot trading pairs, including SLERF, ALPHA, BADGER, OAS, MLN, and AIDOGE, scheduled to take effect between 08:00 and 16:00 on October 23, 2025. OKX advised users to manage their assets and cancel open orders in advance to avoid potential…
Great time to yap about new Enzyme Vaults on Arbitrum, soon 👀
Mona points to where tokenization is heading, and the scale of what’s coming is massive. To seize this opportunity, firms should: - Bring real-world assets onchain with compliance and efficiency. - Innovate by deploying native tokenized instruments to take this movement to the next level. Lucky for them, Enzyme already provides the infrastructure they need. https://t.co/2KeMkkLUIq
How Diva Staking DAO raised $62M in TVL pre-launch 💡 With Enzyme.Blue, they deployed an Early Staker Vault in days with branded vault pages, and transparent rewards without dev overhead. Result: $62M deposits + seamless LP experience. https://enzyme.finance/products/blue?utm_source=x&utm_medium=organic&utm_content=post https://t.co/jNGM7ROwNA
What can you do with Enzyme.Myso? Whether you’re managing a DAO, fund, or treasury, Enzyme.Myso offers structured yield strategies you can directly plug into your workflow: - Treasury Management: Put idle capital to work with a simple, effective solution - Asset Management: Add options to your strategy and unlock instant yield - Hedge Management: Use Enzyme.Myso to earn or hedge as part of broader strategies Enzyme.Myso is natively integrated into Enzyme, enabling decentralized, customizable, and transparent execution for option strategies. Explore more: https://t.co/s95ss93oLu
💪 @Nasdaq has filed with the @SECGov to enable the tokenization and blockchain listing of stocks. This development is a clear signal that the tokenization of traditional financial assets is becoming a priority at the highest levels of market infrastructure. It opens up new…
Everybody builds, but what's the next step? ➡️@staderlabs used Enzyme Vaults to launch their ETHx Hyperloop. ➡️@swissborg introduced the Hyperloop to their 800K+ users, reaching max cap in days! Ready to do the same? Let’s have a chat →http://enzyme.finance/contact-us https://t.co/t33aUnH4vD
$45M+ managed onchain. No custom code. Here’s how @NexusMutual does it with Enzyme 👇 Nexus Mutual needed a secure, transparent, and flexible way to put its capital to work. Enzyme enabled Nexus Mutual to launch a digital asset fund onchain, without the complexity and the need to build a new infrastructure from scratch. With Enzyme Vaults, Nexus Mutual can: • Deploy capital across multiple staking protocols for risk management, all consolidated at the vault level • Streamline operations, no need for complex engineering or security overhead Curious how you can launch and scale your own onchain fund? Let’s talk: https://t.co/2KeMkkLUIq
Every movement needs a catalyst. Enzyme is the mechanism that powers tokenized finance, quietly accelerating a new financial era behind the scenes. Today, we’re doubling down on that role. 1/🧵 https://t.co/ortfCMv9aK
Asset managers told us exactly what they need to bring the next wave of finance onchain: “I want to build and manage cross-chain strategies, not just on one network.” “I need access to any protocol such as DeFi, CEXs, banks, you name it.” “I want to work with any asset, from crypto and NFTs to stocks and RWAs.” So, we built Enzyme.Onyx. Enzyme.Onyx is the wallet tokenization layer for unrestricted, institutional-grade asset management. Three ways we’re solving the industry’s biggest challenges: ① True cross-chain execution: Run strategies seamlessly across blockchains, with all activity and assets consolidated at the vault layer. ② Unrestricted protocol access: Use your Enzyme.Onyx vault to interact with DeFi, CEXs, banks, brokers… no limits. ③ Universal asset support: Reflect, manage, and report on any financial instrument like crypto, NFTs, RWAs, stocks, bonds, etc. directly in your vault. Enzyme.Onyx is built for the innovators designing tomorrow’s global funds and programmable finance products. Explore what’s possible: https://t.co/khpikdKbHe
Incredible to see Enzyme.Myso v3 hit $40M+ in notional settled this year, a record 8x growth in just three months! 🧬 Huge thanks to our community, partners, and everyone exploring what’s possible with Enzyme. Quote [@Mona_El_Isa](https://www.twitter.com/Mona_El_Isa/status/1946915329340522965) > 8x growth unlocked by Enzyme.Myso! 📈 > > Super excited to share a big milestone, Enzyme.Myso v3 has now crossed $40M+ in YTD notional volume (a record 8x growth in three months), with $1.5M+ in premiums paid to users and $172K in protocol fees. 💪 > > What’s even more exciting: we’re… https://t.co/K027OHzGcO
Another milestone for Enzyme.Myso - After crossing $20M in notional just weeks ago, we’ve now reached $1.20M+ in premiums 📈 Here’s where we stand today: • $1.20M+ in total premiums • $33M+ in notional volume • 7× growth over the past 90 days As demand for structured strategies accelerates, Enzyme.Myso is becoming the go-to execution layer for tokenized options and yield. Explore: https://t.co/8oy6LHlQ1O
Summer in Cannes + DeFi, no better combo than this for sure. We are excited to announce that Enzyme goes to @EthCC [8] 🇫🇷 The biggest Web3 event in Europe is just around the corner, and we’re very excited to be in Paris with (almost) the whole team to enjoy the good conversations, good food, and the great energy. We’re not just attending, we’re also bringing the energy with three curated side events designed to connect TradFi, DeFi, and the future of on-chain asset management. Here’s what we’ve got lined up: 🌅 Sea, DeFi & Sun - June 30 Join us in Cannes for a relaxed yet high-caliber brunch by the sea → https://t.co/Xcu8xFSGJw 🌇 Sunset & Assets - July 1 An exclusive evening on La Croisette with organized with our friends at @NexusMutual & @sygnumofficial. TradFi meets Web3 over curated conversations and sunset views → https://t.co/QPDiaBrAVg 🥐 Brunch by the Net - July 2 Enjoy the casual vibes with our partner @chain_security. Good food, sharp minds, and space to talk finance, infra, and what’s next → https://t.co/BxDs2vdx9H We’ll be in town all week. Reach out if you want to meet, partner, or just talk programmable finance. À bientôt!
The question is no longer if tokenized funds will scale, it’s how far they’ll go. According to @Citi, tokenized securities could grow into a $4–5T market by 2030. The World Economic Forum (@wef) estimates that 10% of global GDP could be tokenized and stored on the blockchain by 2027. As we look toward the next decade, the financial system is undergoing a structural rewrite. Since traditional funds face pressure from outdated infrastructure and rising operational costs, tokenized vehicles offer an alternative that’s programmable, composable, and globally accessible. From ETFs and term deposits to structured products and debt instruments, financial logic is moving onchain. In the next cycle, we expect to see: • A big shift towards natively tokenized funds rather than tokenization of existing layers • More institutional experimentation with onchain funds • A new generation of asset managers building directly into DeFi infrastructure • Policy shifts enabling greater clarity and adoption of onchain vehicles Enzyme is built to support this shift with the flexibility to design tokenized strategies natively or bring existing products onchain. Explore the infrastructure behind tomorrow’s fund models → https://t.co/B6hYeELfmM
The question is no longer if tokenized funds will scale, it’s how far they’ll go. According to @Citi, tokenized securities could grow into a $4–5T market by 2030. The World Economic Forum (@wef) estimates that 10% of global GDP could be tokenized and stored on the blockchain by 2027. As we look toward the next decade, the financial system is undergoing a structural rewrite. Since traditional funds face pressure from outdated infrastructure and rising operational costs, tokenized vehicles offer an alternative that’s programmable, composable, and globally accessible. From ETFs and term deposits to structured products and debt instruments, financial logic is moving onchain. In the next cycle, we expect to see: • A big shift towards natively tokenized funds rather then tokenization of existing layers • More institutional experimentation with onchain funds • A new generation of asset managers building directly into DeFi infrastructure • Policy shifts enabling greater clarity and adoption of onchain vehicles Enzyme is built to support this shift with the flexibility to design tokenized strategies natively or bring existing products onchain. Explore the infrastructure behind tomorrow’s fund models → https://t.co/B6hYeELfmM
Glad to support @auroraisnear's marketplace with Enzyme.Onyx by offering chain builders a wallet tokenization layer to strengthen liquidity and drive long-term TVL through bespoke incentivized pools.
Enzyme.Myso v3 just passed $16M in total notional volume. 📈 Launched earlier this year, the protocol is powering covered calls and cash-secured puts at scale, most recently a $1.2M call on $AAVE. It’ll only get bigger from here. Learn more → enzyme.finance/products/myso?…
Enzyme.Myso brings customizable on-chain options to DeFi, enabling secure, non-custodial creation, trading, and management of structured products. Tailor Covered Calls and Cash-Secured Puts to fit your objectives using customizable parameters, from strike prices and expiries to premium decay, auction floors, and delegation rules. Whether you’re a seller seeking instant yield or a trading firm looking to access institutional-grade structured products, Enzyme.Myso enables secure, non-custodial on-chain settlement with: ✅ A broad ERC-20 asset universe ✅ Automated Matchmaking through our universal marketplace ✅ OTC with direct access to cross-firm liquidity ✅ Compatibility with any EVM network Explore the full suite of use cases and start writing on-chain options today: 🧬 https://t.co/Q0abhvRDUL
Introducing Enzyme.Myso, the premier protocol for fully customizable on-chain options strategies. Create, trade, and manage Covered Calls and Cash-Secured Puts, using automated matchmaking or OTC settlement. Start writing options today → enzyme.finance/products/myso
Enzyme 🤝 @arbitrum Did you know that you can create and manage tokenized products & strategies on #Arbitrum using Enzyme.Blue? Whether you're building funds, financial instruments, pools or else, it's all live, fast, and customizable. Proud to be on Arbitrum 💙🧡
Enzyme 🤝 @base Enzyme.Blue, the all-around vault-as-a-service platform is now live on Base! From tokenized funds to financial instruments, projects can now tap into the Base ecosystem to deploy their strategies - fast and efficiently. Learn More ⬇️ 1/🧵
Enzyme.Blue is here! Built for businesses and institutions, Enzyme.Blue is the all-around Vault-as-a-Service platform to create and manage tokenized products. What you build is up to you. Blue makes it possible.
Years in the making. Battle-tested in the wild. Now ready to power tokenized finance at scale, Enzyme is the infrastructure. 1/🧵
Binance will launch FUN and MLN USDT perpetual contracts, with a maximum leverage of up to 50x. binance.com/en/support/ann…
We’re excited to announce that Enzyme has been nominated in 5 categories at the @Hedgeweek Global Digital Assets Awards 2025! ・Blockchain Technology of the Year ・Institutional DeFi Solution of the Year ・Solution Provider of the Year: Innovation ・Solution Provider of the Year: Portfolio Management ・Treasury Management Solution of the Year This wouldn’t be possible without your support, thanks for being part of our journey 🙏 🗳️Now we need your vote, you can vote by April 11: awards.hedgeweek.com/global-digital… #HWAwards
After months of dedication, we’re thrilled to announce the beta release of MYSO v3 🚀 - Create and sell bespoke covered calls to earn instant income - Trade calls seamlessly within our app - Integrate MYSO protocol into your project with ease More ⬇️
Showing 50 of 87 stories · Page 1 of 2. Filters apply to the full news archive.